SC Pharmaceuticals Inc (SCPH) Stock Price, Quote & News

Company Profile

scPharmaceuticals Inc., a pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for the treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresi...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 517 0730

Website: www.scpharmaceuticals.com

Address:

25 Mall Road, Suite 203, Burlington, United States

Ipleadthe5th Aug. 2 at 12:34 AM

$SCPH Love the way it held up on a bloody day

0 · Reply

Damian23 Aug. 1 at 8:30 PM

$SCPH After jobs report, increases the chances of a rate cut, bullish for Bio, stay strong comrades

0 · Reply

BDE_Worldwide Aug. 1 at 6:43 PM

$SCPH P.S. good volume for a Friday!

0 · Reply

BDE_Worldwide Aug. 1 at 6:28 PM

$SCPH should have scooped more sub $5 on that takedown, so predictable.. Have a great weekend all SCPH longs!

1 · Reply

GeniusLoci Aug. 1 at 2:58 PM

$SCPH A little pre-announcement trivia: Companies that move their earnings date earlier than expected have historically tended to share positive news on their earnings calls. This is supported by research from RavenPack, who found that advancing earnings dates correlates positively with good news on the report day SCPH will announce earning on August 7 — a full week earlier than their Q2 2024 release Additionally, research suggests that after-hours announcements tend to see better returns compared to pre-open announcements

1 · Reply

Porkysabe Aug. 1 at 8:44 AM

$SCPH Pumpers come out when it rises and then go into hiding when it goes down! 2nd Quarter is after hours and that should be a tell tale sign!

2 · Reply

Fire7878 Aug. 1 at 5:50 AM

$SCPH got earnings next week 👀

1 · Reply

BDE_Worldwide Jul. 31 at 4:45 PM

$SCPH low volume consolidation.. support at $5..

1 · Reply

MITornado Jul. 31 at 3:22 PM

$SCPH interesting Partnership page on the website, sounds like they would like to sell more than one drug. Whats the goal here?

2 · Reply

RU_REDI_4_ME Jul. 30 at 7:31 PM

$SCPH Wrong!!

0 · Reply

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

May 22, 2025, 7:29 AM EDT - 2 months ago

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025

May 15, 2025, 12:15 AM EDT - 2 months ago

scPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:01 PM EDT - 2 months ago

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

May 7, 2025, 4:01 PM EDT - 3 months ago

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025

May 1, 2025, 4:01 PM EDT - 3 months ago

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Mar 19, 2025, 7:13 PM EDT - 4 months ago

scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:01 PM EDT - 4 months ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 12, 2025, 4:01 PM EDT - 5 months ago

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

Mar 6, 2025, 4:01 PM EST - 5 months ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

Feb 26, 2025, 4:01 PM EST - 5 months ago

scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences

Feb 5, 2025, 4:01 PM EST - 6 months ago

scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 10, 2025, 8:00 AM EST - 7 months ago

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

Nov 13, 2024, 7:05 PM EST - 9 months ago

scPharmaceuticals Inc. (SCPH) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 9 months ago

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024, 4:01 PM EST - 9 months ago

scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

Oct 15, 2024, 8:30 AM EDT - 10 months ago

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

Aug 15, 2024, 5:10 AM EDT - 1 year ago

scPharmaceuticals Inc. (SCPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 12, 2024, 9:48 AM EDT - 1 year ago

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering

Aug 12, 2024, 6:05 AM EDT - 1 year ago

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors

Aug 12, 2024, 6:04 AM EDT - 1 year ago

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure

Aug 12, 2024, 6:02 AM EDT - 1 year ago

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector

Aug 12, 2024, 6:00 AM EDT - 1 year ago

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

May 29, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 14, 2024, 7:02 PM EDT - 1 year ago

scPharmaceuticals Inc. (SCPH) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

May 13, 2024, 4:05 PM EDT - 1 year ago

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 7, 2024, 4:05 PM EDT - 1 year ago

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

Apr 24, 2024, 8:00 AM EDT - 1 year ago

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Mar 13, 2024, 7:32 PM EDT - 1 year ago

scPharmaceuticals Inc (SCPH) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:01 PM EDT - 1 year ago

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Mar 6, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

Feb 28, 2024, 4:01 PM EST - 1 year ago

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

Jan 4, 2024, 4:05 PM EST - 1 year ago

scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue

Nov 12, 2023, 2:57 AM EST - 1 year ago

scPharmaceuticals Q3 Earnings: Cruising Toward Success

Nov 8, 2023, 9:58 PM EST - 1 year ago

scPharmaceuticals Inc (SCPH) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:01 PM EST - 1 year ago

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 1, 2023, 4:05 PM EDT - 1 year ago

scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

Oct 5, 2023, 8:00 AM EDT - 1 year ago

scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 27, 2023, 12:40 AM EDT - 2 years ago

scPharmaceuticals: Furoscix, Charting A Bright Future With FDA's Nod For CKD

Sep 19, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives

Sep 13, 2023, 2:13 PM EDT - 2 years ago

Sizing Up scPharmaceuticals

Sep 5, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 10, 2023, 10:38 PM EDT - 2 years ago

scPharmaceuticals Inc. (SCPH) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:01 PM EDT - 2 years ago

scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 3, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023

Aug 1, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion

Jun 29, 2023, 11:05 PM EDT - 2 years ago

scPharmaceuticals: Oversold Territory, Drug Launch Still Looks Robust

Jun 23, 2023, 8:00 AM EDT - 2 years ago

scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes

Ipleadthe5th Aug. 2 at 12:34 AM

$SCPH Love the way it held up on a bloody day

0 · Reply

Damian23 Aug. 1 at 8:30 PM

$SCPH After jobs report, increases the chances of a rate cut, bullish for Bio, stay strong comrades

0 · Reply

BDE_Worldwide Aug. 1 at 6:43 PM

$SCPH P.S. good volume for a Friday!

0 · Reply

BDE_Worldwide Aug. 1 at 6:28 PM

$SCPH should have scooped more sub $5 on that takedown, so predictable.. Have a great weekend all SCPH longs!

1 · Reply

GeniusLoci Aug. 1 at 2:58 PM

1 · Reply

Porkysabe Aug. 1 at 8:44 AM

$SCPH Pumpers come out when it rises and then go into hiding when it goes down! 2nd Quarter is after hours and that should be a tell tale sign!

2 · Reply

Fire7878 Aug. 1 at 5:50 AM

$SCPH got earnings next week 👀

1 · Reply

BDE_Worldwide Jul. 31 at 4:45 PM

$SCPH low volume consolidation.. support at $5..

1 · Reply

MITornado Jul. 31 at 3:22 PM

$SCPH interesting Partnership page on the website, sounds like they would like to sell more than one drug. Whats the goal here?

2 · Reply

RU_REDI_4_ME Jul. 30 at 7:31 PM

$SCPH Wrong!!

0 · Reply

Spooky22 Jul. 30 at 11:57 AM

$SCPH @OldManLogan I am pretty certain, that SCPharma needs another cash infusion through a PO soon, but I think that will be a good thing. Even though in the short term, this might hurt the SP, in the medium and long term this will a great thing and will make for a last buying opportunity. If the Q2 numbers and/or outlook support the projected growth, I will double down after that happened.

2 · Reply

BDE_Worldwide Jul. 29 at 5:54 PM

$SCPH added..

0 · Reply

richmando Jul. 28 at 12:37 PM

$SCPH where have we heard this before?

1 · Reply

Dundee_Steve Jul. 28 at 10:20 AM

$SCPH Number of SCPH shares shorted are holding steady from 1.53M shares on 6-30-2025 to 1.57M shares on 7-15-2025. This is a positive sign since it implies there is minimal interest in betting against the stock price.

0 · Reply

GeniusLoci Jul. 26 at 4:25 PM

$SCPH

0 · Reply

uscharalph Jul. 25 at 8:05 PM

$SCPH Good close Nice bounce volume Could have gone the other way Can’t wait till earnings

0 · Reply

OldManLogan Jul. 25 at 6:12 PM

$SCPH Great analysis. Long term is very bright here. My only concern is that I don't think they'd let cash dwindle that low, so there might be one more opp to get shares at a discount... Cheers!

1 · Reply

Fire7878 Jul. 25 at 3:31 PM

$SCPH conservative figures.

4 · Reply

Pedelco Jul. 25 at 7:44 AM

$SCPH i‘m ready 🤘 come on 6$

0 · Reply

Dundee_Steve Jul. 24 at 6:36 PM

$SCPH Here are the facts. Shorts have dropped from 5.7M on 3-14-2025 down to 1.5M shares on 6-30-2025. That is a huge 74% reduction in the number of shares shorted. That is very positive for scPharmaceuticals since it implies the stock price will be going up soon.

2 · Reply

hanovk68 Jul. 24 at 4:48 PM

$SCPH so I guess the big question for today is will SCPH close at or above $6/share when the market closes at 4:00pm?

1 · Reply

Fire7878 Jul. 24 at 4:29 PM

$SCPH i think 5.40 to 6.30 will be the channel for the next couple of weeks.

0 · Reply

Market Cap	272.94M
Revenue (ttm)	36.33M
Net Income (ttm)	-85.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-234.38%
Debt to Equity Ratio	-9.95

Volume	396,000
Avg Vol	307,200
Day's Range	N/A - N/A
Shares Out	52.79M
Stochastic %K	16%
Beta	0.40
Analysts	Strong Sell
Price Target	$15.60